Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
Event Now
Search here...
Search
Dose Daily News Bureau
facebook
instagram
linkedin
Exclusive Content
PCI Unveils NEP-Aligned B.Pharm Curriculum for 2026–27 with Focus on AI and Industry Readiness
Breaking News
Dose Daily News Bureau
-
April 17, 2026
FDA Grants Priority Review to Daiichi Sankyo–Merck’s First-in-Class Lung Cancer ADC
Dose daily
Dose Daily News Bureau
-
April 17, 2026
India Moves Toward Affordable Semaglutide with Dr. Reddy’s Laboratories Approval
Breaking News
Dose Daily News Bureau
-
April 16, 2026
India Tightens Oversight as Drugs Controller General of India Targets GLP-1 Misuse
Dose daily
Dose Daily News Bureau
-
April 14, 2026
Viksit Bharat Shiksha Bill Sparks Debate: What It Means for India’s Scientific and Pharma Ecosystem
Dose daily
Dose Daily News Bureau
-
April 13, 2026
Chicago Jury Orders Abbott Laboratories to Pay $70 Million in Premature Infant Formula Case
Dose daily
Dose Daily News Bureau
-
April 12, 2026
1
...
19
20
21
...
41
Page 20 of 41
I want in
I've read and accept the
Privacy Policy
.
ICMR & NCDC Supports Kerala in Managing Nipah Case
Dose Daily News Bureau
-
June 15, 2026
FSSAI Bans Use of Metallic Pins and Wires in Food Packaging
Breaking News
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Breaking News
Hair Color Brands Must Meet New CDSCO Regulations Under Latest Order
Breaking News
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
Breaking News
The FDA has outlined its updated strategy for generic drug oversight
Breaking News
×